Normal view MARC view ISBD view

The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis. [electronic resource]

By:

Tapper, Elliot B

Contributor(s):

Producer: 20170816Description: 987-995 p. digitalISSN:

1534-6080

Subject(s):

Online resources:

Available from publisher's website

In: Transplantation vol. 101

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

341 Preterm Delivery as a Unique Pathophysiologic State Characterized by Maternal Soluble FMS-Like Tyrosine Kinase 1 and Uterine Artery Resistance During Pregnancy: A Longitudinal Cohort Study.
by Straughen, Jennifer K
342 Studies to Prevent Degradation of Recombinant Fc-Fusion Protein Expressed in Mammalian Cell Line and Protein Characterization.
by Chakrabarti, Sanjukta
343 Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
by Zhu, Minglin
344 Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia.
by Lecarpentier, Édouard
345 Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia.
by Zhang, Y-G
346 Periodontitis and placental growth factor in oral fluids are early pregnancy predictors of gestational diabetes mellitus.
by Chaparro, Alejandra
347 Biology of preeclampsia: Combined actions of angiogenic factors, their receptors and placental proteins.
by Huppertz, Berthold
348 Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia: INSPIRE.
by Cerdeira, Ana Sofia
349 [Experimental varicocele affects VEGF and Flt-1 protein expressions in the testis and epididymis of adolescent rats].
by Ai, Qing-yan
350 Evaluation of serum and urinary angiogenic factors in patients with endometriosis.
by Cho, Si Hyun
351 Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study.
by Levine, Richard J
352 VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.
by Waltenberger, Johannes
353 Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.
by Rana, Sarosh
354 Exogenous vascular endothelial growth factor supplementation can restore the podocyte barrier-forming capacity disrupted by sera of preeclamptic women.
by Henao, Daniel E
355 Two-photon microscopy of a Flt1 peptide-hyaluronate conjugate.
by Beack, Songeun
356 Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.
by Rana, Sarosh
357 Correlations between complement system's activation factors and anti-angiogenesis factors in plasma of patients with early/late-onset severe preeclampsia.
by He, Yingdong
358 Dual-cutoff of sFlt-1/PlGF ratio in the stratification of preeclampsia: a systematic review and meta-analysis.
by Zhao, Mutong
359 Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.
by Ehrlich, Laura
360 Serum placental growth factor and soluble fms-like tyrosine kinase 1 at mid-gestation in healthy women: Association with small-for-gestational-age neonates.
by Furuta, Itsuko